Eric Bueter

SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.

A. Dey, D. V. Vander Griend, Steven Kregel, 2023, Cancer letters.

Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain–containing CAR

Philip R. Gafken, R. Orentas, Samuel A. Ritmeester-Loy, 2024, Science Signaling.